Heated tobacco: FDA renews IQOS exposure-modification authorization - Vera Health
FDA renews IQOS exposure-modification authorization, maintaining its status as a modified risk tobacco product. No immediate action required for most retailers, but those selling IQOS must ensure compliance with existing marketing restrictions.
Aforeworn detected this change in the Vape & Tobacco Retail Compliance space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Vape shops and tobacco retailers selling IQOS products should confirm how it applies to their specific situation before acting. There is a time constraint attached: None. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Vape & Tobacco Retail Compliance continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA renewed the exposure-modification order for IQOS, allowing continued marketing as a modified risk product. No new restrictions or requirements.
Who it affects
Vape shops and tobacco retailers selling IQOS products
What you must do
No new action required; continue to comply with existing FDA regulations for modified risk products.
Deadline
None
Never miss a change like this again
Aforeworn watches Vape & Tobacco Retail Compliance around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Vape & Tobacco Retail Compliance
- FDA Authorizes Modified Risk Claims for ZYN Nicotine Pouches: A Landmark Step for Tobacco Harm Reduction - The National Law Review
- FDA Finally Issues Proposed Rule to Require Foreign Tobacco Manufacturers to Register Facilities and List Products - Tobacco Reporter
- FDA Proposal Would Allow Oversight of Foreign Manufacturers - Tobacco Reporter
- Premium Cigar Association Responds to FDA's Proposed Tobacco Product Registration Rule - Premium Cigar Association
- FDA Memo Questions Flavored-Vape Reversal: AP - Tobacco Reporter